FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Original Article
T. Conroy, P. Hammel, M. Hebbar, M.B. Abdelghani, A.C. Wei, J.-L. Raoul, L. Choné, E. Francois, P. Artru, J.J. Biagi, T. Lecomte, E. Assenat, R. Faroux, M. Ychou, J. Volet, A. Sauvanet, G. Breysacher, F.D. Fiore, C. Cripps, P. Kavan, P. Texereau, K. Bouhier-Leporrier, F. Khemissa-Akouz, J.-L. Legoux, B. Juzyna, S. Gourgou, C.J. O’Callaghan, C. Jouffroy-Zeller, P. Rat, D. Malka, F. Castan, and J.-B. Bachet
N Engl J Med 2018;379:2395-2406
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, December 20, 2020 - 11:59pm.